More detail on cost savings program in Q4 report EBITA up, but offset by higher financial costs Comp...
Redeye adjusts its bull and bear case due to a modelling error on terminal EBIT and terminal growth ...
Redeye returns with a more in-depth take on BONESUPPORT’s Q4 report, rendering some changes to our f...
Prostatype is making significant progress, with more than 10 Nordic clinics offering the Prostatype ...
Redeye reviews Qlife’s fourth quarter report. After the end of the quarter, Qlife concluded its prep...
Rapport i linje med estimat Omsättningen för helåret uppgick till 129,6 mkr vs våra estimat om 128,8...
Investment management solid as a rock EBIT estimates raised by 2-4% for 2023e-2024e 2023e EV/EBIT of...
Fortsätter att uppvisa stark hyrestillväxt Intäkter för helåret uppgick till 296 mkr, motsvarande en...
I dag offentliggjorde Angler Gaming sin delårsrapport för det fjärde kvartalet 2022.
Vaisala posted Q4 net sales roughly in line with our estimates.
Aspo’s Q4 didn’t hold big news, however the segments’ EBIT paths may diverge a bit this year after a...
Endomines volumes and revenue for H2 2022 were in line with our estimates yet the profitability was ...
Marimekko’s Q4 net sales came in below our expectations while EBIT was stronger than expected.
Solteq’s Q4 results were weak and below our expectations, with revenue at EUR 16.
NoHo Partners reported Q4 EBIT of EUR 8.5m, +2% versus Refinitiv consensus and +9% versus Nordea.
The go-to-market strategy is now implemented following the split with Thermo Fisher during the quart...
Redeye was hoping for a bit more in terms of Q4 earnings, and so did probably Railcare too.
Redeye states that the quarterly financials were better than expectations, and we expect to adjust o...
Neutral reaction expected to uneventful report NEX-20 in the clinic, no news on NEX-18 timelines Liv...
Starbreeze reported net sales in Q4 of SEK33.6m was in line with our estimate of SEK34.
